Claims for Patent: 10,342,780
✉ Email this page to a colleague
Summary for Patent: 10,342,780
Title: | Compounds useful as kinase inhibitors |
Abstract: | This invention relates to novel compounds. The compounds of the invention are tyrosine kinase inhibitors. Specifically, the compounds of the invention are useful as inhibitors of Bruton's tyrosine kinase (BTK). The invention also contemplates the use of the compounds for treating conditions treatable by the inhibition of Bruton's tyrosine kinase, for example cancer, lymphoma, leukemia and immunological diseases. |
Inventor(s): | Guisot Nicolas |
Assignee: | Loxo Oncology, Inc. |
Application Number: | US16109162 |
Patent Claims: | 12. The compound of claim 1 , wherein the compound is in the form of a pharmaceutically acceptable salt.24. The composition of claim 13 , wherein the compound is in the form of a pharmaceutically acceptable salt. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.